Literature DB >> 20458587

PTA of infrapopliteal arteries: long-term clinical follow-up and analysis of factors influencing clinical outcome.

Jan H Peregrin1, Boris Koznar, Josef Kovác, Jarmila Lastovicková, Jirí Novotný, Daniel Vedlich, Jelena Skibová.   

Abstract

This study was a retrospective analysis of patients with CLI who underwent infrapopliteal percutaneous transluminal angioplasty (PTA). The main goal was to evaluate clinical and morphological factors that influence the clinical outcome of PTA in long-term follow-up. A total of 1,445 PTA procedures were performed in 1,268 patients. Main indications for PTA included gangrene, nonhealing ulcers, or rest pain. The mean number of treated arteries was 1.77 artery/limb, and the majority of lesions were type TASC D. The technical success rate of PTA was 89% of intended-to-treat arteries. The main criterion of clinical success was functional limb salvage (LS). One-year follow-up involved 1,069 limbs. Primary and secondary 1-year LS rates were 76.1 and 84.4%, respectively. The effect of clinical and morphological parameters on the 1-year LS was that the only associated disease with an adverse effect on LS rate was DM combined with dialysis. Regarding limb preprocedural status, gangrene was clearly a negative predictor. The most important factor affecting LS was the number of patent arteries post-PTA: patients with 0, 1, 2, and 3 patent arteries had 1-year primary LS rates of 56.4, 73.1, 80.4, and 83%, respectively. Long-term follow-up of LS rates demonstrated secondary LS rates of 84.4, 78.8, and 73.3% at 1, 5, and 10 years. Every effort should be made to perform PTA for as many arteries as possible, even if TASC D type, to improve clinical outcome. Our study shows that repeat PTA is capable of keeping the long-term LS rate close to 75%.

Entities:  

Mesh:

Year:  2010        PMID: 20458587     DOI: 10.1007/s00270-010-9881-3

Source DB:  PubMed          Journal:  Cardiovasc Intervent Radiol        ISSN: 0174-1551            Impact factor:   2.740


  10 in total

1.  Long-term results of combined aortoiliac and infrainguinal arterial reconstruction for the treatment of critical limb ischemia.

Authors:  Takuya Miyahara; Kunihiro Shigematsu; Ayako Nishiyama; Takuya Hashimoto; Katsuyuki Hoshina; Toshiaki Watanabe
Journal:  Ann Vasc Dis       Date:  2015-02-16

Review 2.  Treating calf and pedal vessel disease: the extremes of intervention.

Authors:  Marco Manzi; Luis M Palena
Journal:  Semin Intervent Radiol       Date:  2014-12       Impact factor: 1.513

Review 3.  Endovascular treatment of infrapopliteal arteries: angioplasty vs stent in the drug-eluting era.

Authors:  Fabrizio Fanelli; Alessandro Cannavale
Journal:  Eur Radiol       Date:  2014-01-30       Impact factor: 5.315

4.  Percutaneous Transluminal Angioplasty and Drug-Eluting Stents for Infrapopliteal Lesions in Critical Limb Ischemia (PADI) Trial.

Authors:  Marlon I Spreen; Jasper M Martens; Bettina E Hansen; Bob Knippenberg; Elke Verhey; Lukas C van Dijk; Jean-Paul P M de Vries; Jan-Albert Vos; Gert Jan de Borst; Evert-Jan P A Vonken; Jan J Wever; Randolph G Statius van Eps; Willem P Th M Mali; Hans van Overhagen
Journal:  Circ Cardiovasc Interv       Date:  2016-02       Impact factor: 6.546

5.  Long-Term Follow-up of the PADI Trial: Percutaneous Transluminal Angioplasty Versus Drug-Eluting Stents for Infrapopliteal Lesions in Critical Limb Ischemia.

Authors:  Marlon I Spreen; Jasper M Martens; Bob Knippenberg; Lukas C van Dijk; Jean-Paul P M de Vries; Jan Albert Vos; Gert Jan de Borst; Evert-Jan P A Vonken; Okker D Bijlstra; Jan J Wever; Randolph G Statius van Eps; Willem P Th M Mali; Hendrik van Overhagen
Journal:  J Am Heart Assoc       Date:  2017-04-14       Impact factor: 5.501

6.  Infrapopliteal angioplasty using a combined angiosomal reperfusion strategy.

Authors:  G K Ambler; A L Stimpson; B G Wardle; D C Bosanquet; U K Hanif; S Germain; C Chick; N Goyal; C P Twine
Journal:  PLoS One       Date:  2017-02-15       Impact factor: 3.240

7.  Focusing on Diabetic Ulcers.

Authors:  C Setacci; D Benevento; G De Donato; E Viviani; U M Bracale; L Del Guercio; G Palasciano; F Setacci
Journal:  Transl Med UniSa       Date:  2020-02-20

8.  Endovascular revascularization for patients with critical limb ischemia: impact on wound healing and long term clinical results in 189 limbs.

Authors:  Jae-Ik Bae; Je Hwan Won; Seung Hwan Han; Sang Hyun Lim; You Sun Hong; Jae-Young Kim; Ji Dae Kim; Jun-Su Kim
Journal:  Korean J Radiol       Date:  2013-05-02       Impact factor: 3.500

9.  Impact of Inherited Prothrombotic Disorders on the Long-Term Clinical Outcome of Percutaneous Transluminal Angioplasty in Patients with Diabetes.

Authors:  Michal Dubský; Alexandra Jirkovská; Libuše Pagáčová; Robert Bém; Andrea Němcová; Vladimíra Fejfarová; Veronika Wosková; Edward B Jude
Journal:  J Diabetes Res       Date:  2015-07-13       Impact factor: 4.011

10.  IN.PACT Amphirion paclitaxel eluting balloon versus standard percutaneous transluminal angioplasty for infrapopliteal revascularization of critical limb ischemia: rationale and protocol for an ongoing randomized controlled trial.

Authors:  Thomas Zeller; Iris Baumgartner; Dierk Scheinert; Marianne Brodmann; Marc Bosiers; Antonio Micari; Patrick Peeters; Frank Vermassen; Mario Landini
Journal:  Trials       Date:  2014-02-19       Impact factor: 2.279

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.